Global Circulating Biomarker for Liquid Biopsy Market Insights and Forecast to 2031

Report ID: 1564159 | Published Date: Jan 2025 | No. of Page: 93 | Base Year: 2024 | Rating: 4.4 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Business Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Circulating Biomarker for Liquid Biopsy Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
        1.2.2 Circulating Tumor Cells (CTCs)
        1.2.3 Circulating Tumor DNA (ctDNA)
        1.2.4 Cell-Free DNA (cfDNA)
        1.2.5 Extracellular Vesicles (EVs)
        1.2.6 Others
    1.3 Market by Application
        1.3.1 Global Circulating Biomarker for Liquid Biopsy Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
        1.3.2 Early Cancer Screening
        1.3.3 Therapy Selection
        1.3.4 Treatment Monitoring
        1.3.5 Recurrence Monitoring Orthopedics
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Circulating Biomarker for Liquid Biopsy Market Perspective (2017-2028)
    2.2 Circulating Biomarker for Liquid Biopsy Growth Trends by Region
        2.2.1 Circulating Biomarker for Liquid Biopsy Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Circulating Biomarker for Liquid Biopsy Historic Market Size by Region (2017-2022)
        2.2.3 Circulating Biomarker for Liquid Biopsy Forecasted Market Size by Region (2023-2028)
    2.3 Circulating Biomarker for Liquid Biopsy Market Dynamics
        2.3.1 Circulating Biomarker for Liquid Biopsy Industry Trends
        2.3.2 Circulating Biomarker for Liquid Biopsy Market Drivers
        2.3.3 Circulating Biomarker for Liquid Biopsy Market Challenges
        2.3.4 Circulating Biomarker for Liquid Biopsy Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Circulating Biomarker for Liquid Biopsy Players by Revenue
        3.1.1 Global Top Circulating Biomarker for Liquid Biopsy Players by Revenue (2017-2022)
        3.1.2 Global Circulating Biomarker for Liquid Biopsy Revenue Market Share by Players (2017-2022)
    3.2 Global Circulating Biomarker for Liquid Biopsy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Circulating Biomarker for Liquid Biopsy Revenue
    3.4 Global Circulating Biomarker for Liquid Biopsy Market Concentration Ratio
        3.4.1 Global Circulating Biomarker for Liquid Biopsy Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Circulating Biomarker for Liquid Biopsy Revenue in 2021
    3.5 Circulating Biomarker for Liquid Biopsy Key Players Head office and Area Served
    3.6 Key Players Circulating Biomarker for Liquid Biopsy Product Solution and Service
    3.7 Date of Enter into Circulating Biomarker for Liquid Biopsy Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Circulating Biomarker for Liquid Biopsy Breakdown Data by Type
    4.1 Global Circulating Biomarker for Liquid Biopsy Historic Market Size by Type (2017-2022)
    4.2 Global Circulating Biomarker for Liquid Biopsy Forecasted Market Size by Type (2023-2028)
5 Circulating Biomarker for Liquid Biopsy Breakdown Data by Application
    5.1 Global Circulating Biomarker for Liquid Biopsy Historic Market Size by Application (2017-2022)
    5.2 Global Circulating Biomarker for Liquid Biopsy Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Circulating Biomarker for Liquid Biopsy Market Size (2017-2028)
    6.2 North America Circulating Biomarker for Liquid Biopsy Market Size by Type
        6.2.1 North America Circulating Biomarker for Liquid Biopsy Market Size by Type (2017-2022)
        6.2.2 North America Circulating Biomarker for Liquid Biopsy Market Size by Type (2023-2028)
        6.2.3 North America Circulating Biomarker for Liquid Biopsy Market Share by Type (2017-2028)
    6.3 North America Circulating Biomarker for Liquid Biopsy Market Size by Application
        6.3.1 North America Circulating Biomarker for Liquid Biopsy Market Size by Application (2017-2022)
        6.3.2 North America Circulating Biomarker for Liquid Biopsy Market Size by Application (2023-2028)
        6.3.3 North America Circulating Biomarker for Liquid Biopsy Market Share by Application (2017-2028)
    6.4 North America Circulating Biomarker for Liquid Biopsy Market Size by Country
        6.4.1 North America Circulating Biomarker for Liquid Biopsy Market Size by Country (2017-2022)
        6.4.2 North America Circulating Biomarker for Liquid Biopsy Market Size by Country (2023-2028)
        6.4.3 U.S.
        6.4.4 Canada
7 Europe
    7.1 Europe Circulating Biomarker for Liquid Biopsy Market Size (2017-2028)
    7.2 Europe Circulating Biomarker for Liquid Biopsy Market Size by Type
        7.2.1 Europe Circulating Biomarker for Liquid Biopsy Market Size by Type (2017-2022)
        7.2.2 Europe Circulating Biomarker for Liquid Biopsy Market Size by Type (2023-2028)
        7.2.3 Europe Circulating Biomarker for Liquid Biopsy Market Share by Type (2017-2028)
    7.3 Europe Circulating Biomarker for Liquid Biopsy Market Size by Application
        7.3.1 Europe Circulating Biomarker for Liquid Biopsy Market Size by Application (2017-2022)
        7.3.2 Europe Circulating Biomarker for Liquid Biopsy Market Size by Application (2023-2028)
        7.3.3 Europe Circulating Biomarker for Liquid Biopsy Market Share by Application (2017-2028)
    7.4 Europe Circulating Biomarker for Liquid Biopsy Market Size by Country
        7.4.1 Europe Circulating Biomarker for Liquid Biopsy Market Size by Country (2017-2022)
        7.4.2 Europe Circulating Biomarker for Liquid Biopsy Market Size by Country (2023-2028)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Circulating Biomarker for Liquid Biopsy Market Size (2017-2028)
    8.2 Asia-Pacific Circulating Biomarker for Liquid Biopsy Market Size by Type
        8.2.1 Asia-Pacific Circulating Biomarker for Liquid Biopsy Market Size by Type (2017-2022)
        8.2.2 Asia-Pacific Circulating Biomarker for Liquid Biopsy Market Size by Type (2023-2028)
        8.2.3 Asia-Pacific Circulating Biomarker for Liquid Biopsy Market Share by Type (2017-2028)
    8.3 Asia-Pacific Circulating Biomarker for Liquid Biopsy Market Size by Application
        8.3.1 Asia-Pacific Circulating Biomarker for Liquid Biopsy Market Size by Application (2017-2022)
        8.3.2 Asia-Pacific Circulating Biomarker for Liquid Biopsy Market Size by Application (2023-2028)
        8.3.3 Asia-Pacific Circulating Biomarker for Liquid Biopsy Market Share by Application (2017-2028)
    8.4 Asia-Pacific Circulating Biomarker for Liquid Biopsy Market Size by Region
        8.4.1 Asia-Pacific Circulating Biomarker for Liquid Biopsy Market Size by Region (2017-2022)
        8.4.2 Asia-Pacific Circulating Biomarker for Liquid Biopsy Market Size by Region (2023-2028)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia 
9 Latin America
    9.1 Latin America Circulating Biomarker for Liquid Biopsy Market Size (2017-2028)
    9.2 Latin America Circulating Biomarker for Liquid Biopsy Market Size by Type
        9.2.1 Latin America Circulating Biomarker for Liquid Biopsy Market Size by Type (2017-2022)
        9.2.2 Latin America Circulating Biomarker for Liquid Biopsy Market Size by Type (2023-2028)
        9.2.3 Latin America Circulating Biomarker for Liquid Biopsy Market Share by Type (2017-2028)
    9.3 Latin America Circulating Biomarker for Liquid Biopsy Market Size by Application
        9.3.1 Latin America Circulating Biomarker for Liquid Biopsy Market Size by Application (2017-2022)
        9.3.2 Latin America Circulating Biomarker for Liquid Biopsy Market Size by Application (2023-2028)
        9.3.3 Latin America Circulating Biomarker for Liquid Biopsy Market Share by Application (2017-2028)
    9.4 Latin America Circulating Biomarker for Liquid Biopsy Market Size by Country
        9.4.1 Latin America Circulating Biomarker for Liquid Biopsy Market Size by Country (2017-2022)
        9.4.2 Latin America Circulating Biomarker for Liquid Biopsy Market Size by Country (2023-2028)
        9.4.3 Mexico
        9.4.4 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Circulating Biomarker for Liquid Biopsy Market Size (2017-2028)
    10.2 Middle East & Africa Circulating Biomarker for Liquid Biopsy Market Size by Type
        10.2.1 Middle East & Africa Circulating Biomarker for Liquid Biopsy Market Size by Type (2017-2022)
        10.2.2 Middle East & Africa Circulating Biomarker for Liquid Biopsy Market Size by Type (2023-2028)
        10.2.3 Middle East & Africa Circulating Biomarker for Liquid Biopsy Market Share by Type (2017-2028)
    10.3 Middle East & Africa Circulating Biomarker for Liquid Biopsy Market Size by Application
        10.3.1 Middle East & Africa Circulating Biomarker for Liquid Biopsy Market Size by Application (2017-2022)
        10.3.2 Middle East & Africa Circulating Biomarker for Liquid Biopsy Market Size by Application (2023-2028)
        10.3.3 Middle East & Africa Circulating Biomarker for Liquid Biopsy Market Share by Application (2017-2028)
    10.4 Middle East & Africa Circulating Biomarker for Liquid Biopsy Market Size by Country
        10.4.1 Middle East & Africa Circulating Biomarker for Liquid Biopsy Market Size by Country (2017-2022)
        10.4.2 Middle East & Africa Circulating Biomarker for Liquid Biopsy Market Size by Country (2023-2028)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE
11 Key Players Profiles
    11.1 Abbott Laboratories
        11.1.1 Abbott Laboratories Company Details
        11.1.2 Abbott Laboratories Business Overview
        11.1.3 Abbott Laboratories Circulating Biomarker for Liquid Biopsy Introduction
        11.1.4 Abbott Laboratories Revenue in Circulating Biomarker for Liquid Biopsy Business (2017-2022)
        11.1.5 Abbott Laboratories Recent Developments
    11.2 Becton, Dickinson and Company
        11.2.1 Becton, Dickinson and Company Company Details
        11.2.2 Becton, Dickinson and Company Business Overview
        11.2.3 Becton, Dickinson and Company Circulating Biomarker for Liquid Biopsy Introduction
        11.2.4 Becton, Dickinson and Company Revenue in Circulating Biomarker for Liquid Biopsy Business (2017-2022)
        11.2.5 Becton, Dickinson and Company Recent Developments
    11.3 GE Healthcare
        11.3.1 GE Healthcare Company Details
        11.3.2 GE Healthcare Business Overview
        11.3.3 GE Healthcare Circulating Biomarker for Liquid Biopsy Introduction
        11.3.4 GE Healthcare Revenue in Circulating Biomarker for Liquid Biopsy Business (2017-2022)
        11.3.5 GE Healthcare Recent Developments
    11.4 Epigenomics AG
        11.4.1 Epigenomics AG Company Details
        11.4.2 Epigenomics AG Business Overview
        11.4.3 Epigenomics AG Circulating Biomarker for Liquid Biopsy Introduction
        11.4.4 Epigenomics AG Revenue in Circulating Biomarker for Liquid Biopsy Business (2017-2022)
        11.4.5 Epigenomics AG Recent Developments
    11.5 Agilent Technologies
        11.5.1 Agilent Technologies Company Details
        11.5.2 Agilent Technologies Business Overview
        11.5.3 Agilent Technologies Circulating Biomarker for Liquid Biopsy Introduction
        11.5.4 Agilent Technologies Revenue in Circulating Biomarker for Liquid Biopsy Business (2017-2022)
        11.5.5 Agilent Technologies Recent Developments
    11.6 Biocept
        11.6.1 Biocept Company Details
        11.6.2 Biocept Business Overview
        11.6.3 Biocept Circulating Biomarker for Liquid Biopsy Introduction
        11.6.4 Biocept Revenue in Circulating Biomarker for Liquid Biopsy Business (2017-2022)
        11.6.5 Biocept Recent Developments
    11.7 Affymetrix
        11.7.1 Affymetrix Company Details
        11.7.2 Affymetrix Business Overview
        11.7.3 Affymetrix Circulating Biomarker for Liquid Biopsy Introduction
        11.7.4 Affymetrix Revenue in Circulating Biomarker for Liquid Biopsy Business (2017-2022)
        11.7.5 Affymetrix Recent Developments
    11.8 Fluxion Biosciences
        11.8.1 Fluxion Biosciences Company Details
        11.8.2 Fluxion Biosciences Business Overview
        11.8.3 Fluxion Biosciences Circulating Biomarker for Liquid Biopsy Introduction
        11.8.4 Fluxion Biosciences Revenue in Circulating Biomarker for Liquid Biopsy Business (2017-2022)
        11.8.5 Fluxion Biosciences Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Author Details
    13.3 Disclaimer

List of Tables
    Table 1. Global Circulating Biomarker for Liquid Biopsy Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
    Table 2. Key Players of Circulating Tumor Cells (CTCs)
    Table 3. Key Players of Circulating Tumor DNA (ctDNA)
    Table 4. Key Players of Cell-Free DNA (cfDNA)
    Table 5. Key Players of Extracellular Vesicles (EVs)
    Table 6. Key Players of Others
    Table 7. Global Circulating Biomarker for Liquid Biopsy Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
    Table 8. Global Circulating Biomarker for Liquid Biopsy Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 9. Global Circulating Biomarker for Liquid Biopsy Market Size by Region (2017-2022) & (US$ Million)
    Table 10. Global Circulating Biomarker for Liquid Biopsy Market Share by Region (2017-2022)
    Table 11. Global Circulating Biomarker for Liquid Biopsy Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 12. Global Circulating Biomarker for Liquid Biopsy Market Share by Region (2023-2028)
    Table 13. Circulating Biomarker for Liquid Biopsy Market Trends
    Table 14. Circulating Biomarker for Liquid Biopsy Market Drivers
    Table 15. Circulating Biomarker for Liquid Biopsy Market Challenges
    Table 16. Circulating Biomarker for Liquid Biopsy Market Restraints
    Table 17. Global Circulating Biomarker for Liquid Biopsy Revenue by Players (2017-2022) & (US$ Million)
    Table 18. Global Circulating Biomarker for Liquid Biopsy Revenue Share by Players (2017-2022)
    Table 19. Global Top Circulating Biomarker for Liquid Biopsy by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Circulating Biomarker for Liquid Biopsy as of 2021)
    Table 20. Ranking of Global Top Circulating Biomarker for Liquid Biopsy Companies by Revenue (US$ Million) in 2021
    Table 21. Global 5 Largest Players Market Share by Circulating Biomarker for Liquid Biopsy Revenue (CR5 and HHI) & (2017-2022)
    Table 22. Key Players Headquarters and Area Served
    Table 23. Key Players Circulating Biomarker for Liquid Biopsy Product Solution and Service
    Table 24. Date of Enter into Circulating Biomarker for Liquid Biopsy Market
    Table 25. Mergers & Acquisitions, Expansion Plans
    Table 26. Global Circulating Biomarker for Liquid Biopsy Market Size by Type (2017-2022) & (US$ Million)
    Table 27. Global Circulating Biomarker for Liquid Biopsy Revenue Market Share by Type (2017-2022)
    Table 28. Global Circulating Biomarker for Liquid Biopsy Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 29. Global Circulating Biomarker for Liquid Biopsy Revenue Market Share by Type (2023-2028)
    Table 30. Global Circulating Biomarker for Liquid Biopsy Market Size by Application (2017-2022) & (US$ Million)
    Table 31. Global Circulating Biomarker for Liquid Biopsy Revenue Share by Application (2017-2022)
    Table 32. Global Circulating Biomarker for Liquid Biopsy Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 33. Global Circulating Biomarker for Liquid Biopsy Revenue Share by Application (2023-2028)
    Table 34. North America Circulating Biomarker for Liquid Biopsy Market Size by Type (2017-2022) & (US$ Million)
    Table 35. North America Circulating Biomarker for Liquid Biopsy Market Size by Type (2023-2028) & (US$ Million)
    Table 36. North America Circulating Biomarker for Liquid Biopsy Market Size by Application (2017-2022) & (US$ Million)
    Table 37. North America Circulating Biomarker for Liquid Biopsy Market Size by Application (2023-2028) & (US$ Million)
    Table 38. North America Circulating Biomarker for Liquid Biopsy Market Size by Country (2017-2022) & (US$ Million)
    Table 39. North America Circulating Biomarker for Liquid Biopsy Market Size by Country (2023-2028) & (US$ Million)
    Table 40. Europe Circulating Biomarker for Liquid Biopsy Market Size by Type (2017-2022) & (US$ Million)
    Table 41. Europe Circulating Biomarker for Liquid Biopsy Market Size by Type (2023-2028) & (US$ Million)
    Table 42. Europe Circulating Biomarker for Liquid Biopsy Market Size by Application (2017-2022) & (US$ Million)
    Table 43. Europe Circulating Biomarker for Liquid Biopsy Market Size by Application (2023-2028) & (US$ Million)
    Table 44. Europe Circulating Biomarker for Liquid Biopsy Market Size by Country (2017-2022) & (US$ Million)
    Table 45. Europe Circulating Biomarker for Liquid Biopsy Market Size by Country (2023-2028) & (US$ Million)
    Table 46. Asia Pacific Circulating Biomarker for Liquid Biopsy Market Size by Type (2017-2022) & (US$ Million)
    Table 47. Asia Pacific Circulating Biomarker for Liquid Biopsy Market Size by Type (2023-2028) & (US$ Million)
    Table 48. Asia Pacific Circulating Biomarker for Liquid Biopsy Market Size by Application (2017-2022) & (US$ Million)
    Table 49. Asia Pacific Circulating Biomarker for Liquid Biopsy Market Size by Application (2023-2028) & (US$ Million)
    Table 50. Asia Pacific Circulating Biomarker for Liquid Biopsy Market Size by Region (2017-2022) & (US$ Million)
    Table 51. Asia Pacific Circulating Biomarker for Liquid Biopsy Market Size by Region (2023-2028) & (US$ Million)
    Table 52. Latin America Circulating Biomarker for Liquid Biopsy Market Size by Type (2017-2022) & (US$ Million)
    Table 53. Latin America Circulating Biomarker for Liquid Biopsy Market Size by Type (2023-2028) & (US$ Million)
    Table 54. Latin America Circulating Biomarker for Liquid Biopsy Market Size by Application (2017-2022) & (US$ Million)
    Table 55. Latin America Circulating Biomarker for Liquid Biopsy Market Size by Application (2023-2028) & (US$ Million)
    Table 56. Latin America Circulating Biomarker for Liquid Biopsy Market Size by Country (2017-2022) & (US$ Million)
    Table 57. Latin America Circulating Biomarker for Liquid Biopsy Market Size by Country (2023-2028) & (US$ Million)
    Table 58. Middle East and Africa Circulating Biomarker for Liquid Biopsy Market Size by Type (2017-2022) & (US$ Million)
    Table 59. Middle East and Africa Circulating Biomarker for Liquid Biopsy Market Size by Type (2023-2028) & (US$ Million)
    Table 60. Middle East and Africa Circulating Biomarker for Liquid Biopsy Market Size by Application (2017-2022) & (US$ Million)
    Table 61. Middle East and Africa Circulating Biomarker for Liquid Biopsy Market Size by Application (2023-2028) & (US$ Million)
    Table 62. Middle East and Africa Circulating Biomarker for Liquid Biopsy Market Size by Country (2017-2022) & (US$ Million)
    Table 63. Middle East and Africa Circulating Biomarker for Liquid Biopsy Market Size by Country (2023-2028) & (US$ Million)
    Table 64. Abbott Laboratories Company Details
    Table 65. Abbott Laboratories Business Overview
    Table 66. Abbott Laboratories Circulating Biomarker for Liquid Biopsy Product
    Table 67. Abbott Laboratories Revenue in Circulating Biomarker for Liquid Biopsy Business (2017-2022) & (US$ Million)
    Table 68. Abbott Laboratories Recent Developments
    Table 69. Becton, Dickinson and Company Company Details
    Table 70. Becton, Dickinson and Company Business Overview
    Table 71. Becton, Dickinson and Company Circulating Biomarker for Liquid Biopsy Product
    Table 72. Becton, Dickinson and Company Revenue in Circulating Biomarker for Liquid Biopsy Business (2017-2022) & (US$ Million)
    Table 73. Becton, Dickinson and Company Recent Developments
    Table 74. GE Healthcare Company Details
    Table 75. GE Healthcare Business Overview
    Table 76. GE Healthcare Circulating Biomarker for Liquid Biopsy Product
    Table 77. GE Healthcare Revenue in Circulating Biomarker for Liquid Biopsy Business (2017-2022) & (US$ Million)
    Table 78. GE Healthcare Recent Developments
    Table 79. Epigenomics AG Company Details
    Table 80. Epigenomics AG Business Overview
    Table 81. Epigenomics AG Circulating Biomarker for Liquid Biopsy Product
    Table 82. Epigenomics AG Revenue in Circulating Biomarker for Liquid Biopsy Business (2017-2022) & (US$ Million)
    Table 83. Epigenomics AG Recent Developments
    Table 84. Agilent Technologies Company Details
    Table 85. Agilent Technologies Business Overview
    Table 86. Agilent Technologies Circulating Biomarker for Liquid Biopsy Product
    Table 87. Agilent Technologies Revenue in Circulating Biomarker for Liquid Biopsy Business (2017-2022) & (US$ Million)
    Table 88. Agilent Technologies Recent Developments
    Table 89. Biocept Company Details
    Table 90. Biocept Business Overview
    Table 91. Biocept Circulating Biomarker for Liquid Biopsy Product
    Table 92. Biocept Revenue in Circulating Biomarker for Liquid Biopsy Business (2017-2022) & (US$ Million)
    Table 93. Biocept Recent Developments
    Table 94. Affymetrix Company Details
    Table 95. Affymetrix Business Overview
    Table 96. Affymetrix Circulating Biomarker for Liquid Biopsy Product
    Table 97. Affymetrix Revenue in Circulating Biomarker for Liquid Biopsy Business (2017-2022) & (US$ Million)
    Table 98. Affymetrix Recent Developments
    Table 99. Fluxion Biosciences Company Details
    Table 100. Fluxion Biosciences Business Overview
    Table 101. Fluxion Biosciences Circulating Biomarker for Liquid Biopsy Product
    Table 102. Fluxion Biosciences Revenue in Circulating Biomarker for Liquid Biopsy Business (2017-2022) & (US$ Million)
    Table 103. Fluxion Biosciences Recent Developments
    Table 104. Research Programs/Design for This Report
    Table 105. Key Data Information from Secondary Sources
    Table 106. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Circulating Biomarker for Liquid Biopsy Market Share by Type: 2021 VS 2028
    Figure 2. Circulating Tumor Cells (CTCs) Features
    Figure 3. Circulating Tumor DNA (ctDNA) Features
    Figure 4. Cell-Free DNA (cfDNA) Features
    Figure 5. Extracellular Vesicles (EVs) Features
    Figure 6. Others Features
    Figure 7. Global Circulating Biomarker for Liquid Biopsy Market Share by Application: 2021 VS 2028
    Figure 8. Early Cancer Screening Case Studies
    Figure 9. Therapy Selection Case Studies
    Figure 10. Treatment Monitoring Case Studies
    Figure 11. Recurrence Monitoring Orthopedics Case Studies
    Figure 12. Circulating Biomarker for Liquid Biopsy Report Years Considered
    Figure 13. Global Circulating Biomarker for Liquid Biopsy Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 14. Global Circulating Biomarker for Liquid Biopsy Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 15. Global Circulating Biomarker for Liquid Biopsy Market Share by Region: 2021 VS 2028
    Figure 16. Global Circulating Biomarker for Liquid Biopsy Market Share by Players in 2021
    Figure 17. Global Top Circulating Biomarker for Liquid Biopsy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Circulating Biomarker for Liquid Biopsy as of 2021)
    Figure 18. The Top 10 and 5 Players Market Share by Circulating Biomarker for Liquid Biopsy Revenue in 2021
    Figure 19. North America Circulating Biomarker for Liquid Biopsy Market Size YoY (2017-2028) & (US$ Million)
    Figure 20. North America Circulating Biomarker for Liquid Biopsy Market Size Market Share by Type (2017-2028)
    Figure 21. North America Circulating Biomarker for Liquid Biopsy Market Size Market Share by Application (2017-2028)
    Figure 22. North America Circulating Biomarker for Liquid Biopsy Market Size Share by Country (2017-2028)
    Figure 23. United States Circulating Biomarker for Liquid Biopsy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 24. Canada Circulating Biomarker for Liquid Biopsy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 25. Europe Circulating Biomarker for Liquid Biopsy Market Size YoY (2017-2028) & (US$ Million)
    Figure 26. Europe Circulating Biomarker for Liquid Biopsy Market Size Market Share by Type (2017-2028)
    Figure 27. Europe Circulating Biomarker for Liquid Biopsy Market Size Market Share by Application (2017-2028)
    Figure 28. Europe Circulating Biomarker for Liquid Biopsy Market Size Share by Country (2017-2028)
    Figure 29. Germany Circulating Biomarker for Liquid Biopsy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 30. France Circulating Biomarker for Liquid Biopsy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 31. U.K. Circulating Biomarker for Liquid Biopsy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 32. Italy Circulating Biomarker for Liquid Biopsy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 33. Russia Circulating Biomarker for Liquid Biopsy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 34. Nordic Countries Circulating Biomarker for Liquid Biopsy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 35. Asia-Pacific Circulating Biomarker for Liquid Biopsy Market Size YoY (2017-2028) & (US$ Million)
    Figure 36. Asia Pacific Circulating Biomarker for Liquid Biopsy Market Size Market Share by Type (2017-2028)
    Figure 37. Asia Pacific Circulating Biomarker for Liquid Biopsy Market Size Market Share by Application (2017-2028)
    Figure 38. Asia Pacific Circulating Biomarker for Liquid Biopsy Market Size Share by Region (2017-2028)
    Figure 39. China Circulating Biomarker for Liquid Biopsy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 40. Japan Circulating Biomarker for Liquid Biopsy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 41. South Korea Circulating Biomarker for Liquid Biopsy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 42. Southeast Asia Circulating Biomarker for Liquid Biopsy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 43. India Circulating Biomarker for Liquid Biopsy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 44. Australia Circulating Biomarker for Liquid Biopsy Market Size YoY Growth (2017-2028) & (US$ Million)
List of Figures
    Figure 45. Latin America Circulating Biomarker for Liquid Biopsy Market Size YoY (2017-2028) & (US$ Million)
    Figure 46. Latin America Circulating Biomarker for Liquid Biopsy Market Size Market Share by Type (2017-2028)
    Figure 47. Latin America Circulating Biomarker for Liquid Biopsy Market Size Market Share by Application (2017-2028)
    Figure 48. Latin America Circulating Biomarker for Liquid Biopsy Market Size Share by Country (2017-2028)
    Figure 49. Mexico Circulating Biomarker for Liquid Biopsy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 50. Brazil Circulating Biomarker for Liquid Biopsy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 51. Middle East & Africa Circulating Biomarker for Liquid Biopsy Market Size YoY (2017-2028) & (US$ Million)
    Figure 52. Middle East and Africa Circulating Biomarker for Liquid Biopsy Market Size Market Share by Type (2017-2028)
    Figure 53. Middle East and Africa Circulating Biomarker for Liquid Biopsy Market Size Market Share by Application (2017-2028)
    Figure 54. Middle East and Africa Circulating Biomarker for Liquid Biopsy Market Size Share by Country (2017-2028)
    Figure 55. Turkey Circulating Biomarker for Liquid Biopsy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 56. Saudi Arabia Circulating Biomarker for Liquid Biopsy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 57. UAE Circulating Biomarker for Liquid Biopsy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 58. Abbott Laboratories Revenue Growth Rate in Circulating Biomarker for Liquid Biopsy Business (2017-2022)
    Figure 59. Becton, Dickinson and Company Revenue Growth Rate in Circulating Biomarker for Liquid Biopsy Business (2017-2022)
    Figure 60. GE Healthcare Revenue Growth Rate in Circulating Biomarker for Liquid Biopsy Business (2017-2022)
    Figure 61. Epigenomics AG Revenue Growth Rate in Circulating Biomarker for Liquid Biopsy Business (2017-2022)
    Figure 62. Agilent Technologies Revenue Growth Rate in Circulating Biomarker for Liquid Biopsy Business (2017-2022)
    Figure 63. Biocept Revenue Growth Rate in Circulating Biomarker for Liquid Biopsy Business (2017-2022)
    Figure 64. Affymetrix Revenue Growth Rate in Circulating Biomarker for Liquid Biopsy Business (2017-2022)
    Figure 65. Fluxion Biosciences Revenue Growth Rate in Circulating Biomarker for Liquid Biopsy Business (2017-2022)
    Figure 66. Bottom-up and Top-down Approaches for This Report
    Figure 67. Data Triangulation
    Figure 68. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Abbott Laboratories
Becton, Dickinson and Company
GE Healthcare
Epigenomics AG
Agilent Technologies
Biocept
Affymetrix
Fluxion Biosciences
Frequently Asked Questions
Circulating Biomarker for Liquid Biopsy report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Circulating Biomarker for Liquid Biopsy report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Circulating Biomarker for Liquid Biopsy report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Orthopedics Devices

Orthopedics Devices market is segmented by Type and by Application. Players, stakeholders, and ot ... Read More